title: The Comparative Oncology Trials Consortium: using spontaneously occurring cancers in dogs to inform the cancer drug development pathway.
authors.affiliation: Radiation Oncology Branch, National Cancer Institute, Bethesda, Maryland, United States of America.
authors.forename: Ira
authors.initials: I
authors.lastname: Gordon
authors.forename: Melissa
authors.initials: M
authors.lastname: Paoloni
authors.forename: Christina
authors.initials: C
authors.lastname: Mazcko
authors.forename: Chand
authors.initials: C
authors.lastname: Khanna
mesh_terms: D000818:Animals; D000829:Animals, Domestic; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000662:veterinary*; D017321:Clinical Trials, Phase I as Topic; D004283:Dog Diseases / Q000188:drug therapy*; D004285:Dogs; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D023421:Models, Animal; D015337:Multicenter Studies as Topic / Q000662:veterinary*; D054547:National Cancer Institute (U.S.) / Q000458:organization & administration*; D009369:Neoplasms / Q000188:drug therapy / Q000662:veterinary*; D013045:Species Specificity; D014481:United States
chemical_list: D000970:Antineoplastic Agents